Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyFri, 07 Jun 2024 15:40:25 +0200Tue, 26 Mar 2024 16:10:00 +0100Human medicines European public assessment report (EPAR): Karvezide, irbesartan,hydrochlorothiazide, Date of authorisation: 16/10/1998, Revision: 48, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/karvezideHuman medicines European public assessment report (EPAR): Karvezide, irbesartan,hydrochlorothiazide, Date of authorisation: 16/10/1998, Revision: 48, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/karvezideTue, 26 Mar 2024 16:10:00 +0100Human medicineKarvezide : EPAR - Scientific Discussionhttps://www.ema.europa.eu/system/files/documents/scientific-discussion/wc500039843_en.pdfKarvezide : EPAR - Scientific Discussionhttps://www.ema.europa.eu/system/files/documents/scientific-discussion/wc500039843_en.pdfMon, 16 Oct 2006 02:00:00 +0200Human medicine